Literature DB >> 21840587

Chronic kidney disease.

Andrew S Levey1, Josef Coresh.   

Abstract

Chronic kidney disease is a general term for heterogeneous disorders affecting kidney structure and function. The 2002 guidelines for definition and classification of this disease represented an important shift towards its recognition as a worldwide public health problem that should be managed in its early stages by general internists. Disease and management are classified according to stages of disease severity, which are assessed from glomerular filtration rate (GFR) and albuminuria, and clinical diagnosis (cause and pathology). Chronic kidney disease can be detected with routine laboratory tests, and some treatments can prevent development and slow disease progression, reduce complications of decreased GFR and risk of cardiovascular disease, and improve survival and quality of life. In this Seminar we discuss disease burden, recommendations for assessment and management, and future challenges. We emphasise clinical practice guidelines, clinical trials, and areas of uncertainty.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21840587     DOI: 10.1016/S0140-6736(11)60178-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  565 in total

Review 1.  Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Chun-Juan Zhai; Xiao-Wei Yang; Jing Sun; Rong Wang
Journal:  Int Urol Nephrol       Date:  2014-11-16       Impact factor: 2.370

2.  A Soft Computing Approach to Kidney Diseases Evaluation.

Authors:  José Neves; M Rosário Martins; João Vilhena; João Neves; Sabino Gomes; António Abelha; José Machado; Henrique Vicente
Journal:  J Med Syst       Date:  2015-08-27       Impact factor: 4.460

Review 3.  Biomarkers in chronic kidney disease, from kidney function to kidney damage.

Authors:  Salvador Lopez-Giacoman; Magdalena Madero
Journal:  World J Nephrol       Date:  2015-02-06

Review 4.  Complement activation in progressive renal disease.

Authors:  Amy Fearn; Neil Stephen Sheerin
Journal:  World J Nephrol       Date:  2015-02-06

Review 5.  Developing better mouse models to study cisplatin-induced kidney injury.

Authors:  Cierra N Sharp; Leah J Siskind
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-19

6.  KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria.

Authors:  Kaori Hayashi; Hiroyuki Sasamura; Mari Nakamura; Tatsuhiko Azegami; Hideyo Oguchi; Yusuke Sakamaki; Hiroshi Itoh
Journal:  J Clin Invest       Date:  2014-05-08       Impact factor: 14.808

Review 7.  Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.

Authors:  Jordi Bover; Lucía Bailone; Víctor López-Báez; Silvia Benito; Paola Ciceri; Andrea Galassi; Mario Cozzolino
Journal:  J Nephrol       Date:  2017-04-21       Impact factor: 3.902

Review 8.  Chronic dialysis in patients with end-stage renal disease: Relevance to kidney xenotransplantation.

Authors:  Abhijit Jagdale; David K C Cooper; Hayato Iwase; Robert S Gaston
Journal:  Xenotransplantation       Date:  2018-11-20       Impact factor: 3.907

9.  Prevalence of pulmonary hypertension in peritoneal dialysis patients: a meta-analysis.

Authors:  Yuanyuan Li; Weifeng Shang; Qiaofa Lu; Bo Zhang; Yali Ren; Yanbo Sun; Junwu Dong
Journal:  Int Urol Nephrol       Date:  2018-11-19       Impact factor: 2.370

10.  The See Kidney Disease Targeted Screening Program for CKD.

Authors:  Lauren E Galbraith; Paul E Ronksley; Lianne J Barnieh; Joanne Kappel; Braden J Manns; Susan M Samuel; Min Jun; Rob Weaver; Nadine Valk; Brenda R Hemmelgarn
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.